Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target entry refers to the broad physiological activation of the host immune system elicited by the administration of live attenuated vaccines for measles, mumps, rubella, and varicella-zoster (MMRV). It is not a single molecular target but a complex biological process involving the coordinated response of the innate and adaptive immune systems. Upon vaccination, the attenuated viruses undergo limited replication, mimicking a natural infection to induce long-lasting humoral and cellular immunity, characterized by the production of neutralizing antibodies and memory T-cells (Source: CDC, 2021). Beyond pathogen-specific protection, live attenuated vaccines like MMRV are recognized for their ability to induce 'trained immunity.' This phenomenon involves epigenetic modifications in innate immune cells that enhance their responsiveness to subsequent, unrelated infections, potentially contributing to a reduction in overall childhood mortality (Source: WHO, 2014; Arts et al., 2018). Clinically, this activation is the primary mechanism for preventing the morbidity and mortality associated with these four viral diseases.
The mechanism involves the stimulation of various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and RIG-I-like receptors, by live attenuated viral components. This triggers the production of type I interferons and proinflammatory cytokines, leading to the maturation of antigen-presenting cells and the subsequent priming of adaptive B-cell and T-cell responses (Source: StatPearls, 2023). Additionally, these live vaccines induce 'trained immunity' through the epigenetic and metabolic reprogramming of innate immune cells, such as monocytes and natural killer cells, which provides non-specific, heterologous protection against unrelated pathogens (Source: Netea et al., Science, 2016).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system (MMRV vaccine-induced activation) (MMRV-IA).